COL18A1 and neoplasm: Antiangiogenic drugs including bevacizumab and recombinant human endostatin constitute another group of targeted drugs that block the tumor's oxygen supply and nutritional supplement by inhibiting angiogenesis and indirectly suppress tumor cell proliferation.9